Top Stocks
Top Analyst Stocks
Top Smart Score Stocks
Top Insiders Stocks
Popular
Stock Screener
Top Online Growth Stocks
Trending Stocks
Penny Stock Screener
Dividend Investing
Dividend Calculator
Dividend Yield Calculator
Dividend Stocks
Dividend News
Dividend Calendar
ETFs
ETF Center
SPY ETF
QQQ ETF
Stock Comparison
ChatGPT Stocks
Value Stocks
Airline Stocks
AI Stocks
Oil Stocks
Bank Stocks
FAANG Stocks
Compare More Stocks…
Calendars
IPO Calendar
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
Market Holidays
Daily Analyst Ratings
Daily Insider Trading
Research Tools
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Stock Market News
Stock Analysis & Ideas
Popular
ETF News
Global Markets News
Expert Spotlight
TipRanks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
News
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
My Watchlist
Smart Portfolio
About Us
About TipRanks
Contact Us
Working with TipRanks
Enterprise Solutions
Tools for Trading Platforms
Data for Hedge Funds
Best Online Brokers
Become an Affiliate
Follow Us
More
Plans
News
Smart Portfolio
Expert Center
Ideas
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed Tools
Try Now
Top Stocks
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
Top Experts
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Research Tools
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Comparisons
Stock Comparison
POPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
Smart Portfolio
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Calendars
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
News
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About Us
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing
LRMR
Stock Latest News
The Fly
Larimar Therapeutics participates in a conference call with William Blair
5d ago
LRMR
The Fly
Larimar Therapeutics reports Q4 EPS (21c), consensus (37c)
6d ago
LRMR
Press Releases
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results
6d ago
LRMR
Press Releases
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
1M ago
LRMR
The Fly
Larimar Therapeutics initiated with a Neutral at Citi
3M ago
LRMR
Press Releases
Larimar Therapeutics to Present at the 34th Annual Piper Sandler Healthcare Conference
4M ago
LRMR
Press Releases
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
4M ago
LRMR
Press Releases
Larimar Therapeutics to Participate in the Guggenheim 4th Annual Immunology & Neurology Day
4M ago
LRMR
Press Releases
Larimar Therapeutics Announces Issuance of U.S. Patent Providing Composition of Matter Protection for CTI-1601
5M ago
LRMR
Press Releases
Larimar Therapeutics Announces Oral and Poster Presentations at the Upcoming International Congress for Ataxia Research
5M ago
LRMR
Market News
Larimar Therapeutics (NASDAQ:LRMR) Stock Climbs on Notable Insider Buying
6M ago
LRMR
Market News
Larimar Therapeutics (NASDAQ:LRMR) Gains after JMP Securities Sees ~400% Upside
6M ago
LRMR
Press Releases
Larimar Therapeutics Announces Closing of Underwritten Offering and Full Exercise of Option to Purchase Additional Shares
6M ago
LRMR
Press Releases
Larimar Therapeutics Announces $70 Million Underwritten Offering
6M ago
LRMR
Press Releases
Larimar Therapeutics Announces FDA Clearance to Initiate the 25 mg Cohort of a Phase 2 Dose Exploration Trial of CTI-1601 in Friedreich’s Ataxia Patients
6M ago
LRMR
Show More
You need to enable JavaScript to run this app.